Covered recipient · General Payments record
EMELINA DOANA BIDDY
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner
General Payments · PY2021
$377.45
- Reported across 17 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2021 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $377.45 | 17 |
By paying entity
PY2021 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $217.94 | 8 |
| TherapeuticsMD, Inc. | $98.72 | 5 |
| Evofem Biosciences, Inc. | $28.32 | 2 |
| Lupin Inc. | $17.83 | 1 |
| MISSION PHARMACAL COMPANY | $14.64 | 1 |
By program year
All program years on this page · sorted by year
| Program year | Amount | Records |
|---|---|---|
| PY2021 | $377.45 | 17 |
Payment records · PY2021 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| AbbVie Inc. | $21.11 | 02/04/2021 | Food and Beverage | Undisputed | 01/23/2026 | 796393259 | CMS |
| AbbVie Inc. | $27.90 | 03/03/2021 | Food and Beverage | Undisputed | 01/23/2026 | 796393261 | CMS |
| AbbVie Inc. | $25.64 | 03/04/2021 | Food and Beverage | Undisputed | 01/23/2026 | 796393263 | CMS |
| AbbVie Inc. | $13.29 | 03/10/2021 | Food and Beverage | Undisputed | 01/23/2026 | 796393265 | CMS |
| AbbVie Inc. | $73.88 | 03/16/2021 | Food and Beverage | Undisputed | 01/23/2026 | 796393267 | CMS |
| AbbVie Inc. | $23.18 | 04/28/2021 | Food and Beverage | Undisputed | 01/23/2026 | 796393269 | CMS |
| AbbVie Inc. | $22.34 | 05/26/2021 | Food and Beverage | Undisputed | 01/23/2026 | 796393271 | CMS |
| AbbVie Inc. | $10.60 | 06/14/2021 | Food and Beverage | Undisputed | 01/23/2026 | 796393273 | CMS |
| Evofem Biosciences, Inc. | $16.48 | 02/10/2021 | Food and Beverage | Undisputed | 01/23/2026 | 855167069 | CMS |
| Evofem Biosciences, Inc. | $11.84 | 04/13/2021 | Food and Beverage | Undisputed | 01/23/2026 | 855167065 | CMS |
| Lupin Inc. | $17.83 | 08/30/2021 | Food and Beverage | Undisputed | 01/23/2026 | 796732351 | CMS |
| Mission Pharmacal Company | $14.64 | 04/01/2021 | Food and Beverage | Undisputed | 01/23/2026 | 754277036 | CMS |
| TherapeuticsMD, Inc. | $11.50 | 02/22/2021 | Food and Beverage | Undisputed | 01/23/2026 | 844957151 | CMS |
| TherapeuticsMD, Inc. | $20.99 | 03/18/2021 | Food and Beverage | Undisputed | 01/23/2026 | 844957175 | CMS |
| TherapeuticsMD, Inc. | $23.55 | 04/15/2021 | Food and Beverage | Undisputed | 01/23/2026 | 844957157 | CMS |
| TherapeuticsMD, Inc. | $21.82 | 05/25/2021 | Food and Beverage | Undisputed | 01/23/2026 | 844957163 | CMS |
| TherapeuticsMD, Inc. | $20.86 | 08/19/2021 | Food and Beverage | Undisputed | 01/23/2026 | 844957170 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021
- Source files
- Dataset page · Bulk file · PY2021
- Generated from
- OP_DTL_GNRL_PGYR2021_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.